Egypt-based private equity firm Ezdehar Management has acquired a minority stake in Yodawy through Ezdehar Mid-Cap Fund II. This strategic investment aligns with Ezdehar’s focus on supporting mid-cap companies in transformative growth phases and marks its entry into the health-tech and pharmaceutical retail sector. Ezdehar Mid-Cap Fund II attracted contributions from international institutions, including the European Bank for Reconstruction and Development (EBRD), the European Investment Bank (EIB), The British International Investment (BII), The Dutch Entrepreneurial Development Bank (FMO), the International Financing Corporation (IFC), Egyptian American Enterprise Fund (EAEF), and the Belgian Investment Company for Developing Countries (BIO), along with a consortium of Egyptian investors.
Legal counsel for Ezdehar Management was provided by Matouk Bassiouny and Hennawy (MBH), while financial and tax matters were overseen by Arc Capital.
Established in 2018, Yodawy is a leading Pharmacy Benefits Management platform and a key player in chronic medication refills across the region. Integrated with major health insurance providers, Yodawy serves 35 payers, 800+ corporates, 20 hospitals, and 30+ clinics. Leveraging technology and robust fulfilment capabilities, Yodawy manages the entire prescription life cycle, enabling doctors to generate e-prescriptions, facilitating real-time insurance approvals, and ensuring timely medication delivery to patients’ doorsteps.
Ezdehar’s substantial investment in Yodawy will primarily focus on supporting the company’s expansion initiatives, including broadening its client base, enhancing tech-enabled fulfilment capabilities, and collaborating with its experienced management team to create additional value. The goal is to solidify Yodawy’s position as the premier Pharmacy Benefit Management player in Egypt and the wider region within the dynamic health-tech space.